BlueOcean Ventures

Type

Venture Capital

Status

Active

Location

Geneve, Switzerland

Total investments

15

Average round size

5M

Portfolio companies

14

Rounds per year

0.94

Lead investments

4

Follow on index

0.07

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalPersonal HealthLife SciencePharmaceuticalNanotechnologyEmergency Medicine

Summary

The main office of represented VC is situated in the Plan-les-ouates. The venture was found in Europe in Switzerland.

The top activity for fund was in 2011. The usual things for fund are deals in the range of 5 - 10 millions dollars. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2019.

Among the most popular fund investment industries, there are Pharmaceutical, Medical Device. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Anergis, Augurix, Viroblock. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BlueOcean Ventures, startups are often financed by Venture Kick, Foundation for Technological Innovation (FIT), Fongit Seed Invest. The meaningful sponsors for the fund in investment in the same round are VINCI CAPITAL, Truffle Capital, Polytech Ventures. In the next rounds fund is usually obtained by Truffle Capital, Sunstone Life Science Ventures, Renaissance PME Foundation.

Besides them, we counted 4 critical employees of this fund in our database.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMedtechHealthcareDeep Tech
Stage focus
Seed
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 36 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
15
Lead investments
4
Exits
1
Rounds per year
0.94
Follow on index
0.07
Investments by industry
  • Health Care (12)
  • Medical (9)
  • Personal Health (7)
  • Biotechnology (6)
  • Medical Device (5)
  • Show 25 more
Investments by region
  • Switzerland (12)
  • France (1)
  • Bulgaria (1)
  • India (1)
Peak activity year
2011

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Group Appearance index
0.73
Avg. company exit year
16

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
12 Mar 2013 Manufacturing, Construction, CleanTech Seed 0 Canada, Dartmouth
Mikajaki 08 Jun 2020 Health Care Seed 2M Switzerland, Geneva
nPloy 23 Nov 2023 Software, Human Resources, Recruiting, Mobile Apps, Outsourcing, Staffing Agency Seed 2M Grad Sofiya, Sofia, Bulgaria

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.